Health - KSYL-AM
Andresr/Getty Images(NEW YORK) -- A breast cancer drug already on the market has been found to lower the chances of breast cancer recurring, an advancement that could open the drug to a broader range of patients. The pharmaceutical company Novartis announced the findings Friday about its breast cancer treatment Kisqali, a drug already approved by the U.S. Food and Drug Administration for people with more advanced stages of breast cancer. The vast majority of breast cancer patients are diagnosed ...
United States Shreeram Aradhye Dennis Slamon Women Cancer Research Program National Cancer Institute Drug Administration
Source: ksyl.com